<DOC>
	<DOCNO>NCT03096223</DOCNO>
	<brief_summary>The objective study evaluate safety tolerability multiple intravenous ( IV ) infusion KHK4083 subject moderate severe atopic dermatitis .</brief_summary>
	<brief_title>A Phase 1 Study KHK4083 Subjects With Atopic Dermatitis</brief_title>
	<detailed_description />
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<criteria>1 . Voluntary write informed consent participate study 2 . Atopic dermatitis diagnose accord Definition Diagnostic Criteria Atopic Dermatitis ( Guidelines Management Atopic Dermatitis 2016 ) establish Japanese Dermatological Association 3 . Moderate severe ( ≥4.5 ) symptom atopic dermatitis screening , accord Rajka &amp; Langeland Severity Index 4 . Investigator Global Assessment ( IGA ) ≥3 ( moderate ) screen 1 . Any following clinically significant concurrent illness : Type 1 diabetes Poorly control type 2 diabetes ( HbA1c &gt; 8.5 % ) Congestive heart failure ( class II IV New York Heart Association classification ) Myocardial infarction within 1 year Unstable angina pectoris within 1 year Poorly control hypertension ( systolic pressure &gt; 150 mm Hg diastolic pressure &gt; 90 mm Hg screening ) Severe chronic lung disease require oxygen therapy Multiple sclerosis demyelinating disease Active malignancy , onset history treatment malignancy within 5 year prior inform consent ( except resect surgically cure epithelial carcinoma uterine cervix , cutaneous basal cell carcinoma , cutaneous squamous cell carcinoma , ductal carcinoma ) 2 . Current past history clinically significant cardiovascular , liver , renal , respiratory , hematologic , central nervous system , psychiatric , autoimmune diseases/disorders 1 ) 3 . Alcohol dependence , drug dependence positive result drug abuse test item 4 . Past current history drug allergy 5 . Any clinically significant infection require hospitalization IV administration antibiotic within 8 week prior preenrollment 6 . Any planned surgical treatment study 7 . Any skin disease may affect clinical symptom assessment 8 . Pregnant lactate woman , woman willing child study period</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>